(Q34934911)

5 August 2017

title

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis (English)

1 reference

5 August 2017

1 reference

Gilbert Spizzo

1

1 reference

5 August 2017

Dominic Fong

2

1 reference

5 August 2017

Martin Wurm

3

1 reference

5 August 2017

Christian Ensinger

4

1 reference

5 August 2017

Peter Obrist

5

1 reference

5 August 2017

Carina Hofer

6

1 reference

5 August 2017

Guido Mazzoleni

7

1 reference

5 August 2017

Guenther Gastl

8

1 reference

5 August 2017

Philip Went

9

1 reference

5 August 2017

language of work or name

English

0 references

publication date

17 March 2011

1 reference

Journal of Clinical Pathology

5 August 2017

published in

1 reference

5 August 2017

volume

64

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

415-420

1 reference

Molecular biomarker analyses using circulating tumor cells

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

Structural and functional characterization of the trifunctional antibody catumaxomab

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

Nuclear signalling by tumour-associated antigen EpCAM

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

EpCAM (CD326) finding its role in cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

MT110: a novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

Frequent EpCam protein expression in human carcinomas

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088404

Ep-CAM overexpression in breast cancer as a predictor of survival

26 October 2018

1 reference

12 December 2020

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831

1 reference

12 December 2020

Wide metastatic spreading in infiltrating lobular carcinoma of the breast

1 reference

12 December 2020

Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours

1 reference

12 December 2020

Association of the 323/A3 surface glycoprotein with tumor characteristics and behavior in human breast cancer

1 reference

12 December 2020

High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer

1 reference

12 December 2020

EpCAM expression in normal, non-pathological tissues

1 reference

12 December 2020

EpCAM expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic features

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.2011.090274

1 reference

5 August 2017

1 reference

5 August 2017

1 reference